AnaptysBio is a clinical-stage biotechnology company based in San Diego, California, that discovers and develops antibody-based medicines for inflammatory and immune-related diseases. Its work centres on therapeutic antibodies designed to modulate immune pathways, and it advances its own pipeline candidates through clinical testing. The company also provides antibody discovery and development services to pharmaceutical partners, generating revenue from collaboration arrangements. Its activities serve patients with immune disorders and the biopharmaceutical industry.
The shares are listed on the London Exchange in UK under the code 0HFQ, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3334 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
24/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-16.6%
From 52-week high-33.2%
MomentumWeak
25/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-14.6%
6-month return-10.0%
Stability (higher is calmer)Weak
26/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)72.7%
Worst drawdown, 1 year (smaller is calmer)-34.8%
LiquidityWeak
14/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M USD
Zero-volume days1.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 40.18 – 73.09Daily closes, split-adjusted
Signals
50-day average52.70
200-day average56.49
Golden/death cross (60d)Death, 24 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.36
Technical summary
Daily
Strongly bearish
1 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
47.67
Bearish
EMA 10
48.00
Bearish
SMA 20
48.11
Bearish
EMA 20
48.76
Bearish
SMA 50
52.70
Bearish
EMA 50
51.49
Bearish
SMA 100
55.30
Bearish
EMA 100
53.73
Bearish
SMA 200
56.49
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
41.99
Neutral
MACD (12, 26)
-1.28
Bearish
Momentum (12)
2.44
Bullish
Stochastic %K (14)
39.16
Neutral
Williams %R (14)
-60.84
Neutral
CCI (20)
-30.16
Neutral
Pivot points (classic, last session)
S3
45.49
S2
46.29
S1
46.70
Pivot
47.50
R1
47.91
R2
48.71
R3
49.12
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
